Overview

Therapeutic Effects of Hydrogen on Steroid-refractory/or Steroid-dependent cGVHD

Status:
Recruiting
Trial end date:
2031-01-01
Target enrollment:
Participant gender:
Summary
This study suggested that hydrogen has a potential as an effective and safe therapeutic agent on cGVHD.
Phase:
Phase 2
Details
Lead Sponsor:
Navy General Hospital, Beijing